These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10853886)

  • 61. Mandatory drug testing in the workplace.
    Hiner J
    Kans Nurse; 1996 Jan; 71(1):2-3. PubMed ID: 8716561
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Screening for drugs of abuse (II): Cannabinoids, lysergic acid diethylamide, buprenorphine, methadone, barbiturates, benzodiazepines and other drugs.
    Simpson D; Braithwaite RA; Jarvie DR; Stewart MJ; Walker S; Watson IW; Widdop B
    Ann Clin Biochem; 1997 Sep; 34 ( Pt 5)():460-510. PubMed ID: 9293303
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of drug testing as an early warning programme: the experience of the Republic of Korea.
    Chung H
    Bull Narc; 2005; 57(1-2):231-48. PubMed ID: 21338024
    [TBL] [Abstract][Full Text] [Related]  

  • 64. When will testing and treatment meet?
    Enos GA
    Behav Healthc; 2009 Jun; 29(6):32-3. PubMed ID: 19655581
    [No Abstract]   [Full Text] [Related]  

  • 65. Analytical approaches of European Union laboratories to drugs of abuse analysis.
    Badia R; de la Torre R; Corcione S; Segura J
    Clin Chem; 1998 Apr; 44(4):790-9. PubMed ID: 9554490
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An overview of forensic drug testing methods and their suitability for harm reduction point-of-care services.
    Harper L; Powell J; Pijl EM
    Harm Reduct J; 2017 Jul; 14(1):52. PubMed ID: 28760153
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ethical aspects of genetic testing in the workplace.
    Holtzman NA
    Community Genet; 2003; 6(3):136-8. PubMed ID: 15237197
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Role of occupational health services in workplace drug testing.
    Lillsunde P; Mukala K; Partinen R; Lamberg M
    Forensic Sci Int; 2008 Jan; 174(2-3):103-6. PubMed ID: 17467212
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Federal employees--random drug and alcohol testing--subject matter jurisdiction--issue preclusion--exhaustion. Whitman v. Department of Transportation.
    Benefits Q; 2007; 23(1):52-3. PubMed ID: 17444084
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Professional drivers and psychoactive substances consumption: results from medical surveillance at the workplace in Piedmont region].
    Rosso GL; Feola M; Rubinetto MP; Petti N; Rubinetto L
    G Ital Med Lav Ergon; 2011; 33(3 Suppl):203-6. PubMed ID: 23393836
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A protocol to evaluate drug-related workplace impairment.
    Reisfield GM; Shults T; Demery J; Dupont R
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):43-8. PubMed ID: 23527668
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A comparative analysis of occupational health and safety risk prevention practices in Sweden and Spain.
    Morillas RM; Rubio-Romero JC; Fuertes A
    J Safety Res; 2013 Dec; 47():57-65. PubMed ID: 24237871
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Overview on drug and alcohol testing in the workplace.
    Hanson M
    Bull Narc; 1993; 45(2):3-44. PubMed ID: 7920541
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of Urine and Oral Fluid for Workplace Drug Testing.
    Casolin A
    J Anal Toxicol; 2016 Sep; 40(7):479-85. PubMed ID: 27344042
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Application of hygrine and cuscohygrine as possible markers to distinguish coca chewing from cocaine abuse on WDT and forensic cases.
    Rubio NC; Strano-Rossi S; Tabernero MJ; Gonzalez JL; Anzillotti L; Chiarotti M; Bermejo AM
    Forensic Sci Int; 2014 Oct; 243():30-4. PubMed ID: 24656326
    [TBL] [Abstract][Full Text] [Related]  

  • 76. LC-MS: a powerful tool in workplace drug testing.
    Gallardo E; Barroso M; Queiroz JA
    Drug Test Anal; 2009 Mar; 1(3):109-15. PubMed ID: 20355182
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies--ADAMHA. Notice.
    Fed Regist; 1990 Dec; 55(238):50882-3. PubMed ID: 10128595
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Substance abuse in the workplace: epidemiology, effects, and industry response.
    Bush DM; Autry JH
    Occup Med; 2002; 17(1):13-25, iii. PubMed ID: 11726333
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Use of illicit substances in the workplace].
    Lhermitte M; Frimat P; Labat L; Haguenoer JM
    Ann Pharm Fr; 2012 Jan; 70(1):3-14. PubMed ID: 22341004
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Accidents and injuries in the EU. Results of the EuroSafe Reports].
    Bauer R; Steiner M; Kisser R; Macey SM; Thayer D
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jun; 57(6):673-80. PubMed ID: 24838539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.